White blood cell counts or leukocytes could be a crucial indicator of COVID-19 severity in women, impacting treatment ...

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.

In resectable, locally advanced esophageal squamous cell carcinoma, neoadjuvant Tyvyt plus chemoradiotherapy led to an ...

Even a mild infection with COVID-19 can promote clogged arteries, increasing the risk of heart attack in some people, a new ...

Hidden within our bones, marrow sustains life by producing billions of blood cells daily, from oxygen-carrying red cells to immune-boosting white cells.

Managing maximum tolerated dose (MTD) chemotherapy while minimizing neutropenia relies on precise complete blood count (CBC) monitoring and AI-powered diagnostics.

A phase 1 study of a personalized cancer vaccine demonstrated antitumor immunity in all treated patients with resected renal ...

A Cownose stingray at the Flordia Aquarium is being recognized as a part of the nationwide World Cancer Day celebration on ...

AI-aided analysis of prenatal ultrasounds detected heart defects more quickly and accurately than doctors evaluating the ...

Among older adults with classical Hodgkin lymphoma, frontline N-AVD has been found to be highly effective and well-tolerated.

X4 Pharmaceuticals is laying off 30% of its staff and halting preclinical R&D as the immune system specialist channels its resources into recently approved rare disease drug mavorixafor.